T2DM is mainly characterized by a progressive decline in insulin action (insulin resistance), followed by the inability of beta cells to compensate for insulin resistance (pancreatic beta cell dysfunction) (Lebovitz and Banerji, 2004). This evidence concerns the gene INS and Insulin resistance.